Hyaluronic acid-engineered Bcl-2 inhibitor nanocrystals for site-specific delivery to breast tumor cells

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. World Health Organization. Breast Cancer (2021). www.who.int/news-room/fact-sheets/detail/breast-cancer
  Google Scholar
• 2. Yin H, Zhao F, Zhang D, Li J. Hyaluronic acid conjugated β-cyclodextrin-oligoethylenimine star polymer for CD44-targeted gene delivery. Int. J. Pharm. 483(2), 169–179 (2015).
  Medline CASGoogle Scholar
• 3. Ni J, Shen TCD, Chen EZ et al. A role for bacterial urease in gut dysbiosis and Crohn's disease. Sci. Transl. Med. 9(416), 1–12 (2017).
  Google Scholar
• 4. Fan J, Zhang Z, Chen H et al. Zinc finger protein 831 promotes apoptosis and enhances chemosensitivity in breast cancer by acting as a novel transcriptional repressor targeting the STAT3/Bcl2 signaling pathway. Genes Dis. 9(12), 1162–1177 (2022).
  Google Scholar
• 5. Voutsadakis IA. Molecular alterations in anti-apoptotic BCL2 family proteins in breast cancer cell line models, drug sensitivities and dependencies to guide the development of BCL2 inhibitors. Gene 847(1), 1–15 (2022).
  Google Scholar
• 6. Rajana N, Mounika A, Chary PS et al. Multifunctional hybrid nanoparticles in diagnosis and therapy of breast cancer. J. Control. Rel. 352(2), 1024–1047 (2022).
  Medline CASGoogle Scholar
• 7. Min Y, Ding X, Yu B, Shen Y, Cong H. Design of sodium lanthanide fluoride nanocrystals for NIR imaging and targeted therapy. Mater. Today Chem. 27(1), 1–26 (2023).
  Google Scholar
• 8. Kumar A, Valamla B, Thakor P, Chary PS, Rajana N, Mehra NK. Development and evaluation of nanocrystals loaded hydrogel for topical application. J. Drug Deliv. Sci. Technol. 74(4), 1–15 (2022). •• Exhaustive summary about nanocrystals and their characterizations.
  Google Scholar
• 9. Junghanns J-UAH, Müller RH. Nanocrystal technology, drug delivery and clinical applications. Int. J. Nanomed. 3(3), 295 (2008).
  Medline CASGoogle Scholar
• 10. Psimadas D, Georgoulias P, Valotassiou V, Loudos G. Molecular nanomedicine towards cancer. J. Pharm. Sci. 101(7), 2271–2280 (2012).
  Medline CASGoogle Scholar
• 11. de Waard H, Grasmeijer N, Hinrichs WLJ, Eissens AC, Pfaffenbach PPF, Frijlink HW. Preparation of drug nanocrystals by controlled crystallization: application of a 3-way nozzle to prevent premature crystallization for large scale production. Eur. J. Pharm. Sci. 38(3), 224–229 (2009).
  Medline CASGoogle Scholar
• 12. Cheng W, Nie J, Xu L et al. PH-sensitive delivery vehicle based on folic acid-conjugated polydopamine-modified mesoporous silica nanoparticles for targeted cancer therapy. ACS Appl. Mater. Interface 9(22), 18462–18473 (2017).
  Medline CASGoogle Scholar
• 13. Jiang T, Chen G, Shi X, Guo R. Hyaluronic acid-decorated laponite^® nanocomposites for targeted anticancer drug delivery. Polymers (Basel) 11(1), 1–14 (2019).
  Google Scholar
• 14. Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat. Rev. Cancer 4(7), 528–539 (2004).
  Medline CASGoogle Scholar
• 15. Chen Y, Peng F, Song X, Wu J, Yao W, Gao X. Conjugation of paclitaxel to C-6 hexanediamine-modified hyaluronic acid for targeted drug delivery to enhance antitumor efficacy. Carbohydr. Polym. 181(1), 150–158 (2018). •• Indicates that hyaluronic acid is beneficial for drug targeting with enhanced antitumor efficacy.
  Medline CASGoogle Scholar
• 16. Ding YW, Zhang XW, Mi CH, Qi XY, Zhou J, Wei DX. Recent advances in hyaluronic acid-based hydrogels for 3D bioprinting in tissue engineering applications. Smart Mater. Med. 4(1), 59–68 (2023).
  Google Scholar
• 17. Zheng X, Wang B, Tang X et al. Absorption, metabolism, and functions of hyaluronic acid and its therapeutic prospects in combination with microorganisms: a review. Carbohydr. Polym. 299(1), 1–16 (2023). • Provide comprehensive information about hyaluronic acid, its function in CD44 targeting and how it is significant in site-specific delivery.
  Google Scholar
• 18. Sun CY, Zhang BB, Zhou JY. Light-activated drug release from a hyaluronic acid targeted nanoconjugate for cancer therapy. J. Mater. Chem. B. 7(7), 4843–4853 (2019).
  Medline CASGoogle Scholar
• 19. Zhong Y, Goltsche K, Cheng L et al. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo. Biomaterials 84(2), 250–261 (2016).
  Medline CASGoogle Scholar
• 20. Zhao Q, Liu J, Zhu W et al. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells. Acta Biomater. 23(5), 147–156 (2015).
  MedlineGoogle Scholar
• 21. Peer D, Margalit R. Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal doxorubicin in syngeneic and human xenograft mouse tumor models. Neoplasia 6(4), 343–353 (2004).
  Medline CASGoogle Scholar
• 22. Dufaÿ A, Hillaireau H, Leite T et al. Hyaluronic acid-bearing lipoplexes: physico-chemical characterization and in vitro targeting of the CD44 receptor. J. Control. Rel. 162(3), 545–552 (2012).
  MedlineGoogle Scholar
• 23. Costabile G, Provenzano R, Azzalin A et al. PEGylated mucus-penetrating nanocrystals for lung delivery of a new FtsZ inhibitor against Burkholderia cenocepacia infection. Nanomed. Nanotechnol. Biol. Med. 23(1), 1–12 (2012).
  Google Scholar
• 24. Khan S, de Matas M, Zhang J, Anwar J. Nanocrystal preparation: low-energy precipitation method revisited. Cryst. Growth Des. 13(7), 2766–2777 (2013).
  CASGoogle Scholar
• 25. Ran Q, Wang M, Kuang W et al. Advances of combinative nanocrystal preparation technology for improving the insoluble drug solubility and bioavailability. Crystals 12(9), 1–21 (2022). •• Significant article that provide ideas to develop nanocrystals for improving the aqueous solubility of drug cargos.
  Google Scholar
• 26. Saka R, Jain H, Kommineni N, Chella N, Khan W. Enhanced penetration and improved therapeutic efficacy of bexarotene via topical liposomal gel in imiquimod induced psoriatic plaque model in BALB/c mice. J. Drug Deliv. Sci. Technol. 58(1), 1–34 (2020).
  Google Scholar
• 27. Khutale GV, Casey A. Synthesis and characterization of a multifunctional gold-doxorubicin nanoparticle system for pH triggered intracellular anticancer drug release. Eur. J. Pharm. Biopharm. 119(6), 372–380 (2017).
  Medline CASGoogle Scholar
• 28. Zakaria AS, Afifi SA, Elkhodairy KA. Newly developed topical cefotaxime sodium hydrogels: antibacterial activity and in vivo evaluation. Biomed. Res. Int. 14(3), 1–15 (2016).
  Google Scholar
• 29. Guntner AS, Doppler C, Wechselberger C, Bernhard D, Buchberger W. HPLC-MS/MS shows that the cellular uptake of all-trans-retinoic acid under hypoxia is downregulated by the novel active agent 5-methoxyleoligin. Cells 9(9), 2048–2060 (2020). • Provides information on the quantitative determination of cellular uptake using high-performance liquid chromatography methodology.
  Medline CASGoogle Scholar
• 30. Sharma M, Mittapelly N, Banala VT et al. Amalgamated microneedle array bearing ribociclib-loaded transfersomes eradicates breast cancer via CD44 targeting. Biomacromolecules 23(3), 661–675 (2022).
  Medline CASGoogle Scholar
• 31. Hao J, Wang F, Wang X, Zhang D, Bi Y, Gao Y. Development and optimization of baicalin-loaded solid lipid nanoparticles prepared by coacervation method using central composite design. Eur. J. Pharm. Sci. 47(2), 497–505 (2012).
  Medline CASGoogle Scholar
• 32. Ojugo ASE, Mcsheehy PMJ, Mcintyre DJO et al. Measurement of the extracellular pH of solid tumours in mice by magnetic resonance spectroscopy: a comparison of exogenous 19 F and 31 P probes. NMR Biomed. Mater. 8(1), 495–504 (1998).
  Google Scholar
• 33. Bose P, Gandhi VV, Konopleva MY. Pathways and mechanisms of venetoclax resistance. Leuk. Lymphoma 58(9), 2026–2039 (2017).
  CASGoogle Scholar
• 34. Ghanem A, Al-Karmalawy AA, Abd El Maksoud AI et al. Rumex vesicarius L. extract improves the efficacy of doxorubicin in triple-negative breast cancer through inhibiting Bcl2, mTOR, JNK1 and augmenting p21 expression. Informat. Med. Unlocked 29(2), 1–10 (2022).
  Google Scholar
• 35. Liu C, Wu C. Optimization of nanostructured lipid carriers for lutein delivery. Colloid. Surf. A 353(2), 149–156 (2010).
  CASGoogle Scholar